

Cover Story
COVID-19 & CancerFree
By Matthew Bin Han Ong
Community oncology practices in the United States are reeling from a sharp decrease in business—whether you look at new patients, chemotherapy visits, or non-chemo visits—the result of reduced activity and stay-at-home orders across the country to mitigate the spread of SARS-CoV-2.
COVID-19 Updates
In Brief
Clinical Roundup
Drugs & Targets
Trending Stories
- On Capitol Hill, NIH gets congressional support and RFK Jr. gets slammed
- House committee’s FY26 spending bill increases NCI funding by $48M, NIH by $99M
House joins Senate in rejecting Trump’s proposed 40% NIH cuts - Franco Muggia, former head of CTEP and NYU cancer center, dies at 85
- Bhattacharya fields NCAB’s questions about funding, political involvement in grant review, DEI, animal testing
- After stormy Senate hearing, Trump offers tepid support for RFK Jr. while Kennedy family members call for his ouster
- Lowy: Forward-funding policy forced NCI to drastically reduce RPG awards funded for FY25, 10% of NCI staff has been lost